Su, C., Liao, Z., Mo, J., Liu, F., Wang, W., Zhang, H., Zhang, H., Liu, Y., Pan, Y., Zhu, H., Chen, X., Zhang, Z., Zhu, P., Zhang, B. (2025). VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilization. Nature Communications. https://doi.org/10.1038/s41467-025-64079-6